- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
IPCA Laboratories Limited — Board Meeting, 13-08-2026: Outcome of Board Meeting
13-08-2026 | 01:35 pm
13-08-2026 | 01:35 pm
Ipca Labs announced the financial results for the quarter: consolidated net profit surged 80% to ₹422.81 Cr, with total income up 20% to ₹2813.36 Cr. The board also approved the amalgamation of Krebs Biochemicals & Industries Ltd., effective April 1, 2026, pending approvals.
No comments yet. Be the first to comment!